交易 G1 Therapeutics - GTHX CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
G1 Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 4.14 | -0.11 | -2.59% | 4.25 | 4.25 | 4.01 |
Apr 17, 2024 | 4.25 | 0.27 | 6.78% | 3.98 | 4.33 | 3.97 |
Apr 16, 2024 | 4.05 | -0.12 | -2.88% | 4.17 | 4.29 | 3.97 |
Apr 15, 2024 | 4.28 | -0.26 | -5.73% | 4.54 | 4.54 | 4.16 |
Apr 12, 2024 | 4.50 | -0.10 | -2.17% | 4.60 | 4.67 | 4.37 |
Apr 11, 2024 | 4.65 | 0.08 | 1.75% | 4.57 | 4.77 | 4.52 |
Apr 10, 2024 | 4.62 | 0.03 | 0.65% | 4.59 | 4.66 | 4.39 |
Apr 9, 2024 | 4.85 | 0.16 | 3.41% | 4.69 | 4.87 | 4.63 |
Apr 8, 2024 | 4.74 | 0.05 | 1.07% | 4.69 | 4.82 | 4.30 |
Apr 5, 2024 | 4.75 | 0.21 | 4.63% | 4.54 | 4.80 | 4.44 |
Apr 4, 2024 | 4.53 | -0.21 | -4.43% | 4.74 | 4.80 | 4.43 |
Apr 3, 2024 | 4.69 | 0.19 | 4.22% | 4.50 | 4.80 | 4.47 |
Apr 2, 2024 | 4.57 | 0.12 | 2.70% | 4.45 | 4.65 | 4.35 |
Apr 1, 2024 | 4.52 | 0.26 | 6.10% | 4.26 | 4.61 | 4.10 |
Mar 28, 2024 | 4.29 | -0.19 | -4.24% | 4.48 | 4.64 | 4.28 |
Mar 27, 2024 | 4.46 | 0.16 | 3.72% | 4.30 | 4.73 | 4.25 |
Mar 26, 2024 | 4.28 | 0.12 | 2.88% | 4.16 | 4.36 | 4.10 |
Mar 25, 2024 | 4.10 | 0.18 | 4.59% | 3.92 | 4.32 | 3.92 |
Mar 22, 2024 | 3.97 | 0.29 | 7.88% | 3.68 | 4.06 | 3.61 |
Mar 21, 2024 | 3.67 | 0.24 | 7.00% | 3.43 | 3.71 | 3.42 |
G1 Therapeutics Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Wednesday, May 1, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 G1 Therapeutics Inc Earnings Release Q1 2024 G1 Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, June 14, 2024 | ||
時間 (UTC) 11:30 | 國家 US
| 事件 G1 Therapeutics Inc Annual Shareholders Meeting G1 Therapeutics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Wednesday, July 31, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q2 2024 G1 Therapeutics Inc Earnings Release Q2 2024 G1 Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 51.301 | 31.476 | 45.285 | 0 | 0 |
收入 | 51.301 | 31.476 | 45.285 | 0 | 0 |
總營業費用 | 187.479 | 173.733 | 141.761 | 129.041 | 89.286 |
銷售/一般/行政費用,總計 | 101.033 | 96.491 | 69.445 | 40.648 | 18.603 |
研究與開發 | 82.698 | 75.426 | 72.316 | 88.393 | 70.683 |
營業收入 | -136.178 | -142.257 | -96.476 | -129.041 | -89.286 |
其他,淨值 | 0.003 | -0.546 | -0.542 | 6.594 | 3.998 |
稅前淨收入 | -145.859 | -147.427 | -97.844 | -122.447 | -85.288 |
稅後淨收入 | -147.559 | -148.352 | -99.254 | -122.447 | -85.288 |
未計算非常項目前的淨收益 | -147.559 | -148.352 | -99.254 | -122.447 | -85.288 |
淨收入 | -147.559 | -148.352 | -99.254 | -122.447 | -85.288 |
Total Adjustments to Net Income | 0 | 0 | 0 | ||
普通股股東可獲收益 (不含非經常性項目) | -147.559 | -148.352 | -99.254 | -122.447 | -85.288 |
普通股股東可獲收益 (含非經常性項目) | -147.559 | -148.352 | -99.254 | -122.447 | -85.288 |
攤薄調整 | |||||
攤薄淨收入 | -147.559 | -148.352 | -99.254 | -122.447 | -85.288 |
攤薄後加權平均股 | 43.6261 | 41.9434 | 37.878 | 37.4993 | 33.3167 |
扣除特別項目的每股攤薄盈利 | -3.38235 | -3.53696 | -2.62036 | -3.26532 | -2.55992 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -3.38235 | -3.54005 | -2.62036 | -3.26532 | -2.55992 |
利息收入(費用),非經營淨值 | -9.684 | -4.624 | -0.826 | ||
收入成本,共計 | 3.748 | 2.016 | |||
毛利 | 47.553 | 29.46 | |||
異常費用(收入) | -0.2 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 42.392 | 12.946 | 10.25 | 23.576 | 10.573 |
收入 | 42.392 | 12.946 | 10.25 | 23.576 | 10.573 |
收入成本,共計 | 1.404 | 1.459 | 0.992 | 1.111 | 0.976 |
毛利 | 40.988 | 11.487 | 9.258 | 22.465 | 9.597 |
總營業費用 | 30.876 | 38.692 | 41.137 | 45.124 | 47.535 |
銷售/一般/行政費用,總計 | 17.432 | 21.753 | 23.558 | 24.432 | 25.716 |
研究與開發 | 12.04 | 15.48 | 16.587 | 19.581 | 20.843 |
營業收入 | 11.516 | -25.746 | -30.887 | -21.548 | -36.962 |
利息收入(費用),非經營淨值 | -2.067 | -2.373 | -2.518 | -2.553 | -2.357 |
其他,淨值 | 0.569 | 0.524 | 0.237 | 0.048 | -0.127 |
稅前淨收入 | 10.018 | -27.595 | -33.168 | -24.053 | -39.446 |
稅後淨收入 | 8.71 | -27.595 | -33.649 | -25.272 | -39.446 |
未計算非常項目前的淨收益 | 8.71 | -27.595 | -33.649 | -25.272 | -39.446 |
淨收入 | 8.71 | -27.595 | -33.649 | -25.272 | -39.446 |
普通股股東可獲收益 (不含非經常性項目) | 8.71 | -27.595 | -33.649 | -25.272 | -39.446 |
普通股股東可獲收益 (含非經常性項目) | 8.71 | -27.595 | -33.649 | -25.272 | -39.446 |
攤薄淨收入 | 8.71 | -27.595 | -33.649 | -25.272 | -39.446 |
攤薄後加權平均股 | 61.0405 | 51.6479 | 46.309 | 42.7993 | 42.7077 |
扣除特別項目的每股攤薄盈利 | 0.14269 | -0.53429 | -0.72662 | -0.59048 | -0.92363 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | 0.14269 | -0.53429 | -0.72662 | -0.59048 | -0.92363 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 179.5 | 243.565 | 216.392 | 271.003 | 370.133 |
現金和短期投資 | 145.07 | 221.186 | 207.306 | 269.208 | 369.29 |
現金等價物 | 94.594 | 221.186 | 207.306 | 269.208 | 369.29 |
預付的費用 | 7.094 | 13.157 | 8.786 | 1.732 | 0.843 |
總資産 | 187.965 | 254.094 | 228.552 | 284.831 | 371.27 |
物業/廠房/設備,總計 - 淨額 | 7.951 | 9.048 | 10.508 | 13.391 | 1.137 |
物業/廠房/設備,總計 - 總額 | 9.777 | 10.344 | 11.335 | 14.068 | 1.459 |
累計折舊,總計 | -1.826 | -1.296 | -0.827 | -0.677 | -0.322 |
流動負債總額 | 35.588 | 27.613 | 23.443 | 19.769 | 12.362 |
應付賬款 | 7.431 | 2.897 | 3.572 | 3.684 | 3.377 |
預提費用 | 26.692 | 24.295 | 17.474 | 16.085 | 8.985 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 1.465 | 0.421 | 2.397 | ||
負債總額 | 119.218 | 110.553 | 51.201 | 29.304 | 12.45 |
長期債務總額 | 77.015 | 75.19 | 19.893 | 0 | 0 |
股權 | 68.747 | 143.541 | 177.351 | 255.527 | 358.82 |
Redeemable Preferred Stock | |||||
普通股 | 0.005 | 0.004 | 0.004 | 0.004 | 0.004 |
留存收益(累計赤字) | -732.018 | -584.459 | -436.107 | -336.853 | -214.406 |
Treasury Stock - Common | -0.008 | -0.008 | -0.008 | -0.008 | -0.008 |
總負債和股東權益 | 187.965 | 254.094 | 228.552 | 284.831 | 371.27 |
已發行普通股總數 | 51.4994 | 42.5621 | 38.1141 | 37.6116 | 37.2421 |
其他負債,總計 | 6.615 | 7.75 | 7.865 | 9.535 | 0.088 |
額外實收資本 | 800.768 | 728.004 | 613.462 | 592.384 | 573.23 |
其他流動資産,總計 | 0.063 | 0.063 | 0.063 | 0.063 | |
其他長期資産,總計 | 0.514 | 1.481 | 1.652 | 0.437 | |
應收賬款總額,淨額 | 11.094 | 5.688 | 0.237 | ||
應收賬款 - 貿易,淨額 | 11.094 | 5.688 | 0.237 | ||
長期債務 | 77.015 | 75.19 | 19.893 | ||
總庫存 | 16.179 | 3.471 | |||
短期投資 | 50.476 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 126.103 | 140.436 | 153.965 | 179.5 | 157.465 |
現金和短期投資 | 94.352 | 104.231 | 116.317 | 145.07 | 122.982 |
現金等價物 | 52.623 | 55.914 | 68.237 | 94.594 | 93.238 |
應收賬款總額,淨額 | 9.265 | 13.171 | 16.025 | 11.094 | 10.521 |
應收賬款 - 貿易,淨額 | 9.265 | 13.171 | 16.025 | 11.094 | 10.521 |
總庫存 | 13.491 | 15.6 | 15.543 | 16.179 | 13.95 |
預付的費用 | 8.932 | 7.371 | 6.017 | 7.094 | 9.949 |
其他流動資産,總計 | 0.063 | 0.063 | 0.063 | 0.063 | 0.063 |
總資産 | 133.097 | 147.891 | 161.957 | 187.965 | 166.573 |
物業/廠房/設備,總計 - 淨額 | 6.78 | 7.173 | 7.564 | 7.951 | 8.365 |
物業/廠房/設備,總計 - 總額 | 8.995 | 9.261 | 9.522 | 9.777 | 10.054 |
累計折舊,總計 | -2.215 | -2.088 | -1.958 | -1.826 | -1.689 |
其他長期資産,總計 | 0.214 | 0.282 | 0.428 | 0.514 | 0.743 |
流動負債總額 | 33.653 | 33.912 | 33.69 | 35.588 | 37.134 |
應付賬款 | 7.335 | 5.762 | 5.38 | 7.431 | 8.442 |
預提費用 | 24.181 | 24.681 | 22.767 | 26.692 | 27.251 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 2.137 | 3.469 | 5.543 | 1.465 | 1.441 |
負債總額 | 90.075 | 90.343 | 116.969 | 119.218 | 120.608 |
長期債務總額 | 51.246 | 50.936 | 77.47 | 77.015 | 76.558 |
長期債務 | 51.246 | 50.936 | 77.47 | 77.015 | 76.558 |
其他負債,總計 | 5.176 | 5.495 | 5.809 | 6.615 | 6.916 |
股權 | 43.022 | 57.548 | 44.988 | 68.747 | 45.965 |
普通股 | 0.005 | 0.005 | 0.005 | 0.005 | 0.004 |
額外實收資本 | 812.132 | 808.454 | 804.604 | 800.768 | 744.338 |
留存收益(累計赤字) | -769.107 | -750.903 | -759.613 | -732.018 | -698.369 |
Treasury Stock - Common | -0.008 | -0.008 | -0.008 | -0.008 | -0.008 |
總負債和股東權益 | 133.097 | 147.891 | 161.957 | 187.965 | 166.573 |
已發行普通股總數 | 51.8099 | 51.7085 | 51.6593 | 51.4994 | 42.8971 |
短期投資 | 41.729 | 48.317 | 48.08 | 50.476 | 29.744 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -147.559 | -148.352 | -99.254 | -122.447 | -85.288 |
經營活動産生的現金 | -128.62 | -132.108 | -83.742 | -99.571 | -74.307 |
經營活動産生的現金 | 0.53 | 0.469 | 0.582 | 0.356 | 0.175 |
非現金物品 | 23.716 | 24.613 | 19.006 | 16.449 | 10.233 |
營運資金的變化 | -5.307 | -8.838 | -4.076 | 6.071 | 0.573 |
投資活動産生的現金 | -50.529 | 0 | 0.152 | -2.716 | -0.709 |
資本支出 | -0.506 | 0 | -2.716 | -0.709 | |
融資活動産生的現金 | 52.495 | 145.863 | 21.688 | 2.705 | 340.494 |
融資現金流項目 | -0.043 | -1.411 | -0.62 | 0 | -0.892 |
股票的發行(報廢),淨額 | 52.538 | 92.274 | 2.308 | 2.705 | 341.386 |
現金淨變化 | -126.654 | 13.755 | -61.902 | -99.582 | 265.478 |
已付現金利息 | 7.924 | 2.908 | 0.997 | ||
其他投資現金流量項目,總計 | -50.023 | 0 | 0.152 | ||
債務的發行(退還),淨額 | 0 | 55 | 20 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -27.595 | -147.559 | -113.91 | -88.638 | -49.192 |
Cash From Operating Activities | -29.053 | -128.62 | -97.988 | -76.741 | -38.184 |
Cash From Operating Activities | 0.132 | 0.53 | 0.393 | 0.254 | 0.115 |
Non-Cash Items | 4.75 | 23.716 | 18.876 | 13.433 | 7.071 |
Cash Interest Paid | 2.512 | 7.924 | 5.61 | 3.537 | 1.716 |
Changes in Working Capital | -6.34 | -5.307 | -3.347 | -1.79 | 3.822 |
Cash From Investing Activities | 2.91 | -50.529 | -30.167 | -0.506 | 0 |
Capital Expenditures | -0.506 | -0.506 | -0.506 | ||
Cash From Financing Activities | -0.214 | 52.495 | 0.145 | 0.018 | 0.018 |
Financing Cash Flow Items | -0.215 | -0.043 | 0 | 0 | 0 |
Issuance (Retirement) of Stock, Net | 0.001 | 52.538 | 0.145 | 0.018 | 0.018 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | |
Net Change in Cash | -26.357 | -126.654 | -128.01 | -77.229 | -38.166 |
Other Investing Cash Flow Items, Total | 2.91 | -50.023 | -29.661 | 0 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
700 Park Offices Drive
Suite 200
RESEARCH TRIANGLE PARK
NORTH CAROLINA 27709
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易